Health TidingsKyverna Reports Sustained Clinical Benefit With miv-cel in Refractory RA Kyverna Reports Sustained Clinical Benefit With miv-cel in Refractory RA Read Post »
Health Tidings Mergers & AcquisitionsCytomX Secures Expanded Regeneron Partnership Worth Up to $4 Billion CytomX Secures Expanded Regeneron Partnership Worth Up to $4 Billion Read Post »
GenericsLupin and Natco Secure FDA Approval for Eribulin Mesylate Injection Lupin and Natco Secure FDA Approval for Eribulin Mesylate Injection Read Post »
Health TidingsMannKind Advances Inhaled Nintedanib into Phase 2 Trial for IPF MannKind Advances Inhaled Nintedanib into Phase 2 Trial for IPF Read Post »
Health TidingsPrimary Endpoint Miss Leads Praxis to Reassess Vormatrigine Strategy Primary Endpoint Miss Leads Praxis to Reassess Vormatrigine Strategy Read Post »
Health TidingsVera’s Atacicept Heads Toward Full Approval After FDA Aligns on Earli... Vera’s Atacicept Heads Toward Full Approval After FDA Aligns on Earli... Read Post »
Health TidingsLantern Reports Durable LP-300 Responses in EGFR L858R Lung Cancer Lantern Reports Durable LP-300 Responses in EGFR L858R Lung Cancer Read Post »
Health TidingsRoche’s Giredestrant Wins FDA Priority Review for Early Breast Cancer Roche’s Giredestrant Wins FDA Priority Review for Early Breast Cancer Read Post »
Health Tidings Mergers & AcquisitionsCEPI Backs Moderna’s Bundibugyo Ebola Vaccine with $50 Million CEPI Backs Moderna’s Bundibugyo Ebola Vaccine with $50 Million Read Post »
Health TidingsFDA Accepts Vertex’s Povetacicept After Strong Phase 3 IgAN Results FDA Accepts Vertex’s Povetacicept After Strong Phase 3 IgAN Results Read Post »
Health Tidings Mergers & AcquisitionsServier Acquires Edgewise Muscular Dystrophy Business for Up to $2.65 Billi... Servier Acquires Edgewise Muscular Dystrophy Business for Up to $2.65 Billi... Read Post »
Health TidingsUCB, Biogen Report Positive PHOENYCS GO Results in SLE UCB, Biogen Report Positive PHOENYCS GO Results in SLE Read Post »
Health TidingsPfizer’s BRAFTOVI Cuts Progression Risk by 56% in BRAF V600E mCRC Pfizer’s BRAFTOVI Cuts Progression Risk by 56% in BRAF V600E mCRC Read Post »
Health TidingsRevMed’s Daraxonrasib Cuts Death Risk by 60% in PDAC RevMed’s Daraxonrasib Cuts Death Risk by 60% in PDAC Read Post »
Health TidingsIndustry Perspective: What Wockhardt’s ZAYNICH FDA Approval Means for Pat... Industry Perspective: What Wockhardt’s ZAYNICH FDA Approval Means for Pat... Read Post »
Health TidingsOtsuka Reports Positive Phase 3 Results of Centanafadine in Adult ADHD Ahea... Otsuka Reports Positive Phase 3 Results of Centanafadine in Adult ADHD Ahea... Read Post »
Health TidingsEU Expands Comirnaty Authorization for Children Under 5 EU Expands Comirnaty Authorization for Children Under 5 Read Post »
Health TidingsMHRA Approves Sanofi’s Rilzabrutinib for Adults with Chronic ITP MHRA Approves Sanofi’s Rilzabrutinib for Adults with Chronic ITP Read Post »
Health TidingsWHO Endorses Regeneron’s Maftivimab for Bundibugyo Ebola Trials WHO Endorses Regeneron’s Maftivimab for Bundibugyo Ebola Trials Read Post »
Health TidingsBMS’s Mezigdomide Hits Phase 3 Goal in Relapsed Myeloma BMS’s Mezigdomide Hits Phase 3 Goal in Relapsed Myeloma Read Post »
Health TidingsMerck Advances Calderasib With FDA Breakthrough Therapy Designation in Lung... Merck Advances Calderasib With FDA Breakthrough Therapy Designation in Lung... Read Post »
Health TidingsPhase 2b Failure Ends Agios’ Tebapivat Program in Lower-Risk MDS Phase 2b Failure Ends Agios’ Tebapivat Program in Lower-Risk MDS Read Post »
Health TidingsReplimune Aligns with FDA on RP1 Resubmission Path in Advanced Melanoma Replimune Aligns with FDA on RP1 Resubmission Path in Advanced Melanoma Read Post »
Health TidingsFDA Extends Review of Beren’s Adrabetadex NDA for Infantile-Onset NPC FDA Extends Review of Beren’s Adrabetadex NDA for Infantile-Onset NPC Read Post »
Health Tidings Mergers & AcquisitionsPfizer and Innovent Strike Oncology Deal Worth Up to $10.5 Billion Pfizer and Innovent Strike Oncology Deal Worth Up to $10.5 Billion Read Post »
Health TidingsLilly Secures Nationwide PBM Coverage for Obesity Portfolio Lilly Secures Nationwide PBM Coverage for Obesity Portfolio Read Post »
Health TidingsFDA Starts Priority Review of Venglustat for Neurological Gaucher Disease FDA Starts Priority Review of Venglustat for Neurological Gaucher Disease Read Post »
Health TidingsFDA Grants Priority Review to Cogent’s Bezuclastinib in Second-Line GIST FDA Grants Priority Review to Cogent’s Bezuclastinib in Second-Line GIST Read Post »
Health TidingsCorcept Plans NDA Resubmission for Relacorilant in Cushing’s Syndrome Corcept Plans NDA Resubmission for Relacorilant in Cushing’s Syndrome Read Post »
Health TidingsFDA Grants Breakthrough Therapy Designation to Terns’ TERN‑701 in CML FDA Grants Breakthrough Therapy Designation to Terns’ TERN‑701 in CML Read Post »
Health TidingsJapan Grants Orphan Drug Designation to Vanda’s Imsidolimab for GPP Japan Grants Orphan Drug Designation to Vanda’s Imsidolimab for GPP Read Post »
Health TidingsFDA Accepts NDA for BBP‑418 in LGMD2I/R9, Grants Priority Review FDA Accepts NDA for BBP‑418 in LGMD2I/R9, Grants Priority Review Read Post »
Health Tidings Mergers & AcquisitionsApogee Secures Up to $1.3 Billion From Blackstone to Advance Zumilokibart i... Apogee Secures Up to $1.3 Billion From Blackstone to Advance Zumilokibart i... Read Post »
Health TidingsFDA Begins Priority Review of Nuvalent’s Neladalkib After Accepting NDA FDA Begins Priority Review of Nuvalent’s Neladalkib After Accepting NDA Read Post »
Health TidingsFDA Extends Review of Camizestrant in ESR1‑Mutant Breast Cancer FDA Extends Review of Camizestrant in ESR1‑Mutant Breast Cancer Read Post »
Health TidingsFDA OND Backs LYTENAVA Efficacy, Clearing Path Toward Approval FDA OND Backs LYTENAVA Efficacy, Clearing Path Toward Approval Read Post »
Health Tidings Mergers & AcquisitionsLilly Acquires Curevo, LimmaTech, and Vaccine Company to Expand Vaccine Por... Lilly Acquires Curevo, LimmaTech, and Vaccine Company to Expand Vaccine Por... Read Post »
Health TidingsAstellas Unveils Five-Year Growth Strategy Focused on Pipeline Expansion an... Astellas Unveils Five-Year Growth Strategy Focused on Pipeline Expansion an... Read Post »
Health TidingsPoolbeg Reports Positive FDA Meeting for POLB 001 CRS Program Poolbeg Reports Positive FDA Meeting for POLB 001 CRS Program Read Post »
GenericsLupin Enters China With NMPA Approval for Pediatric Flu Drug Lupin Enters China With NMPA Approval for Pediatric Flu Drug Read Post »
Health TidingsImmunovant Halts Batoclimab After Phase 3 TED Miss, Shifts Focus to IMVT‑... Immunovant Halts Batoclimab After Phase 3 TED Miss, Shifts Focus to IMVT‑... Read Post »
Health TidingsGilead Advances Trodelvy in Europe With CHMP Nod for First-Line TNBC Gilead Advances Trodelvy in Europe With CHMP Nod for First-Line TNBC Read Post »
Health TidingsCHMP Issues Positive Opinion for Camizestrant in ESR1‑Mutant Breast Cance... CHMP Issues Positive Opinion for Camizestrant in ESR1‑Mutant Breast Cance... Read Post »
Health TidingsCHMP Endorses Novo Nordisk’s Single-Dose Wegovy 7.2 mg Pen CHMP Endorses Novo Nordisk’s Single-Dose Wegovy 7.2 mg Pen Read Post »
Health TidingsCHMP May 2026 Roundup: EU Backs New Treatments Across Oncology, Obesity, an... CHMP May 2026 Roundup: EU Backs New Treatments Across Oncology, Obesity, an... Read Post »
Health TidingsANKTIVA Plus BCG Shows Economic Edge in NMIBC CIS ANKTIVA Plus BCG Shows Economic Edge in NMIBC CIS Read Post »
Health TidingsRegeneron’s Otarmeni™ Accepted for EMA Review Under Accelerated Assessm... Regeneron’s Otarmeni™ Accepted for EMA Review Under Accelerated Assessm... Read Post »
Health TidingsRegeneron Reports Strong Early Lynozyfic Data in AL Amyloidosis Regeneron Reports Strong Early Lynozyfic Data in AL Amyloidosis Read Post »
Health TidingsEMA Accepts TEV-‘749 Application for Adults With Schizophrenia EMA Accepts TEV-‘749 Application for Adults With Schizophrenia Read Post »
Health Tidings Mergers & AcquisitionsJohnson & Johnson Builds AI-Powered Surgical Network in Abu Dhabi Johnson & Johnson Builds AI-Powered Surgical Network in Abu Dhabi Read Post »
